Proposed Main Entrance

PROJECT OVERVIEW

Proposed Building Design

Mr. Kishor Mehta and Mrs. Charu Mehta being son and daughter-in-law of Mr. Kirtilal Manilal Mehta are instrumental in setting up the multispecialty tertiary care Lilavati Hospital, Mumbai. The Founder/ Permanent Trustee Mr. Kishor Mehta & Mrs. Charu Mehta having knowledge and experience of managing a hospital are ambitious to set up a world class multispecialty hospital in name of “Lilavati Foundation” in Gujarat along with their sons Mr. Prashant Mehta & Mr. Rajesh Mehta. Lilavati Foundation is to be set up in their personal capacity at GIFT City, Gandhinagar, Gujarat.

The vision of the hospital is to provide tertiary and quaternary care services. The entity proposes to set up a 300-bed hospital consisting of 250 census beds & 50 non-census beds at Plot 47A in the Block 47, in GIFT City, Gandhi Nagar, Gujarat.

Project Highlight
1st Multispeciality Tertiary Care Hospital in GIFT City

With 300 a bed capacity the proposed project will be the 1st Hospital in GIFT City with state of art infrastructure

Vision of Providing Best in Class Treatment

The vision of the hospital will be to provide tertiary and quaternary care services; 30% of the census beds proposed are in single, deluxe and suite category.

High Population Growth Rate

Ahmedabad is ranked 51st among the world's fastest growing megacities & it is expected to surpass 10 million population by 2030.

A greenfield site with good market opportunity aided by excellent connectivity.
One of the few hospitals in the geography with all tertiary & quaternary care services under one roof.
Experience and expertise of the promoters in operating a leading multispecialty tertiary care hospital.
Location advantage
  • GSRTC City Bus Stand - 8.4 km
  • GSRTS Gandhinagar Bus Stand - 11.1 km
  • Gandhinagar Capital Railway Station - 14.4 km
  • Sardar Vallabhbhai Patel International Airport - 19.1 km
  • Ahmedabad Junction - 23.0 km
  • Ahmedabad Bus Stand - 29.3 km
Construction Update as till date 1th May 2024